Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
OncoResponse
3205
OncoResponse
Technology
Biotechnology
OncoResponse is a company providing cancer research into immunotherapies and the newest technologies for oncologists.
Suggest edits
Type
B2c
Founded
2015
Raised
$50M
Follow us
Also headquartered in Houston
NASA
DialWebHosting
Cameron
Kinder Morgan
real
ConocoPhillips
EVgo
Halliburton
Schlumberger
Sean Spicer
Companies in the same industry
MGC Pharmaceuticals
Solid GT
RC21X
Shattuck Labs
Zhejiang POCTech Corporation
RS Research
EnteroBiotix
QUE Oncology
Microscopy Innovations
Neurovia
Alexa global traffic share
Overview
Funding
4
Add info
Latest funding
Show all
$40,000,000
Venture capital (Series B) - 2018
Canaan Partners
Redmile Group
ARCH Venture Partners
+6
$3,000,000
Venture capital (Series A) - 2017
Team Size
1–10
Employees
I work here
Location
Houston
,
United States
Headquarters
Explore Houston
GeekWire
Seattle biotech OncoResponse raises $40.6M to create antibody-based treatments for cancer
$40,000,000
Venture capital (Series B)
FinSMEs
,
PE HUB
,
Xconomy
, +1
OncoResponse Raises $40M in Series B Financing
Funding
Health
